These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35238985)

  • 1. [Bacterial hepatobiliary infections : Pathogen spectrum, antimicrobial resistance and current treatment concepts].
    Bruns T; Stallmach A
    Internist (Berl); 2022 Apr; 63(4):349-366. PubMed ID: 35238985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary diseases as main causes of pyogenic liver abscess caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Shi SH; Feng XN; Lai MC; Kong HS; Zheng SS
    Liver Int; 2017 May; 37(5):727-734. PubMed ID: 27718321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020.
    Dunne MW; Aronin SI; Yu KC; Watts JA; Gupta V
    BMC Infect Dis; 2022 Feb; 22(1):194. PubMed ID: 35227203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018.
    Kohler P; Wolfensberger A; Stampf S; Brönnimann A; Boggian K; van Delden C; Favre M; Hirzel C; Khanna N; Kuster SP; Manuel O; Neofytos D; Ragozzino S; Schreiber PW; Walti L; Mueller NJ;
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):50. PubMed ID: 33678189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
    Toh HS; Chuang YC; Huang CC; Lee YL; Liu YM; Ho CM; Lu PL; Liu CE; Chen YH; Wang JH; Ko WC; Yu KW; Liu YC; Chen YS; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S18-23. PubMed ID: 22749054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
    Lee Y; Lee DG; Lee SH; Yoo KH
    J Korean Med Sci; 2016 Nov; 31(11):1808-1813. PubMed ID: 27709861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S; Weber R; Zbinden R; Ruef C; Hasse B
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2021 Apr; 72(7):e169-e183. PubMed ID: 33106864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Rapid Immunochromatographic Tests for the Direct Detection of Extended Spectrum Beta-Lactamases and Carbapenemases in Enterobacterales Isolated from Positive Blood Cultures.
    Keshta AS; Elamin N; Hasan MR; Pérez-López A; Roscoe D; Tang P; Suleiman M
    Microbiol Spectr; 2021 Dec; 9(3):e0078521. PubMed ID: 34878297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors and antimicrobial susceptibility pattern of extended spectrum β-lactamase-producing bacteria in a tertiary care hospital.
    Chandrasekhar D; Chalilparambil J; Kallungal SM; Pattani D; Chandrakumar A; Pokkavayalil V
    J Basic Clin Physiol Pharmacol; 2016 Mar; 27(2):155-62. PubMed ID: 26812867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
    Biedenbach DJ; Bouchillon SK; Hoban DJ; Hackel M; Phuong DM; Nga TT; Phuong NT; Phuong TT; Badal RE
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):463-7. PubMed ID: 24923210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with biliary tract infection.
    Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Dig Dis Sci; 2013 Mar; 58(3):841-9. PubMed ID: 22975797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial profile and patterns of antimicrobial drug resistance in intra-abdominal infections: current experience in a teaching hospital.
    Shree N; Arora BS; Mohil RS; Kasana D; Biswal I
    Indian J Pathol Microbiol; 2013; 56(4):388-92. PubMed ID: 24441227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa).
    Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ
    Clin Infect Dis; 2021 Apr; 72(7):1109-1116. PubMed ID: 33830222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in causative pathogens of acute cholangitis and their antimicrobial susceptibility over a period of 6 years.
    Kwon JS; Han J; Kim TW; Oh JH; Kwon HH; Jung JT; Kwon JG; Kim EY; Kim HG
    Korean J Gastroenterol; 2014 May; 63(5):299-307. PubMed ID: 24870302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N; Rao P; Arora J; Dogra A
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
    Cantón R; Loza E; Aznar J; Castillo FJ; Cercenado E; Fraile-Ribot PA; González-Romo F; López-Hontangas JL; Rodríguez-Lozano J; Suárez-Barrenechea AI; Tubau F; Díaz-Regañón J; López-Mendoza D;
    Rev Esp Quimioter; 2019 Apr; 32(2):145-155. PubMed ID: 30761824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative faecal abundance of extended-spectrum β-lactamase-producing Enterobacterales and its impact on infections among intensive care unit patients: a pilot study.
    Pilmis B; Mizrahi A; Péan de Ponfilly G; Philippart F; Bruel C; Zahar JR; Le Monnier A
    J Hosp Infect; 2021 Jun; 112():92-95. PubMed ID: 33794294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
    Akram M; Shahid M; Khan AU
    Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.